Aardvark Therapeutics (AARD) Misses Q4 EPS by 81c

Aardvark Therapeutics (NASDAQ: AARD) reported Q4 EPS of ($0.81).

For earnings history and earnings-related data on Aardvark Therapeutics (AARD) click here.

You May Also Be Interested In

• Important Notice to Long-Term Shareholders Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); GoDaddy Inc. (NYSE: GDDY); and The Simply Good Foods Company (NASDAQ: SMPL);
• Janus Living (JAN) 7500 contracts of September 35 calls trade
• Interactive Brokers (IBKR) call put ratio 1 call 1.2 puts as share price down 6.2%